https://israelhealthcarenews.com/article/909469904-intercure-announces-2025-results-with-nis-270-million-in-revenue-and-positive-operating-cash-flow Israel Healthcare News en PressRelease 2026-04-30T22:05:00+00:00 InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow https://ml.globenewswire.com/media/7ccabaed-d117-4a39-a756-85fc081ede2f/small/logo-jpg.jpg https://israelhealthcarenews.com/article/909340879-teva-s-2025-healthy-future-report-highlights-environmental-and-access-to-medicines-progress-including-meeting-all-sustainability-linked-bond-targets Israel Healthcare News en PressRelease 2026-04-30T12:30:00+00:00 Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://israelhealthcarenews.com/article/909341014-enlivex-treasury-portfolio-update-listing-of-the-rain-token-on-htx-a-leading-cryptocurrency-exchange Israel Healthcare News en PressRelease 2026-04-30T12:30:00+00:00 Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange https://ml.globenewswire.com/media/27d4e006-8709-4fd1-8341-5b58381487d4/small/picture1-jpg.jpg https://israelhealthcarenews.com/article/909019660-brainsway-to-report-first-quarter-2026-financial-results-on-may-13-2026 Israel Healthcare News en PressRelease 2026-04-29T12:00:00+00:00 BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/ea01c8f7-39be-46d2-a8e0-bc05994f170e/small/brainsway-2021-logo-jpg.jpg https://israelhealthcarenews.com/article/909004923-teva-delivers-strong-q1-2026-results-driven-by-innovative-portfolio-growth-and-disciplined-execution Israel Healthcare News en PressRelease 2026-04-29T11:00:00+00:00 Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://israelhealthcarenews.com/article/909004885-teva-to-acquire-emalex-biosciences-adding-nda-ready-first-in-class-therapy-to-neuroscience-pipeline-and-accelerating-teva-s-pivot-to-growth-strategy Israel Healthcare News en PressRelease 2026-04-29T10:30:00+00:00 Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg